Properties
Description
KGA-2727 is a sodium-glucose cotransporter inhibitor, preventing the kidneys from reabsorbing glucose.
Molecular Formula
C26H40N4O8
Identity
Confirmed by NMR/HPLC/MS.
Applications
KGA-2727 is studied for its role in modulating glucose levels through SGLT inhibition, relevant to metabolic disorder treatments.
